Alicaforsen (ISIS 2302)

allicaforsen · Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alicaforsen (ISIS 2302), covering 2022-08-15 to 2022-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease [Phase 3]